You are here: Industry Insights > small molecule

News List

Favored by Capital and Hot Among Pharma Companies, This Small-molecule Degradation Agent Company Has Great Potential PharmaSources/Xiaobing
March 21, 2022
While many pharmaceutical companies are chasing targeted and immunotherapy therapeutic drugs, protein degradation therapy has also attracted the attention of more and more companies and has become another new direction in the field of new drug R&D.
Lonza Expands Solid Small Molecule Services contractpharma
February 18, 2021
To encompass all aspects of solid form screening and characterization of small molecule APIs.
Ajinomoto Bio-Pharma expands small molecule manufacturing capabilities in India expresspharma
August 14, 2020
Ajinomoto Bio-Pharma Services announced expansion of small molecule manufacturing capabilities with the addition of a new production facility in Visakhapatnam, India.
Top 10 Small Molecule Drugs: A Half were Oncology Drugs PharmaSources/Yuntian
April 24, 2019
Small molecule drugs still have a huge share in the global market at present, and are the biggest source of drugs.
Evotec and Galapagos collaborate for new fibrosis target pharmaceutical-technology
February 20, 2019
German biotechnology company Evotec has entered into a collaboration agreement with Belgo-Dutch pharmaceutical firm Galapagos for a new, undisclosed target to treat fibrosis....
Philogen Announces Drug Discovery Collaboration With Johnson & Johnson Innovation pharmafocusasia
January 25, 2019
Philogen S.p.A., a privately-owned biotechnology company, today announced through its wholly-owned Swiss subsidiary, Philochem AG, a collaboration agreement with Janssen Biotech, Inc. ....
Cambrex Expands Capacity and Capabilites in Sweden contractpharma
May 31, 2017
Installs new multi-purpose reactors, adds continuous flow technology at Karlskoga Facility
Regen BioPharma Sees Additional Positive Results for Modulating NR2F6 Checkpoint americanpharmaceuticalreview
May 17, 2017
Regen BioPharma states that progress continues to be achieved by Regen in developing small molecule drugs that activate and inhibit NR2F6.
Cambrex Invests to Increase Pilot Scale API Capacity contractpharma
May 17, 2017
Increases High Point, NC, facility reactor capacity by 30%
Lhasa and Optibrium enter research and product development collaboration pharmaasia
April 24, 2017
Drug discovery software specialists combine expertise to extend studies into drug metabolism modelling

Previous page 1 2 Next page